An Extension Study for Participants Who Have Completed the Treatment Period of a Qualifying Parent Study

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 20, 2021

Primary Completion Date

November 20, 2023

Study Completion Date

November 20, 2023

Conditions
Dermatomyositis
Interventions
DRUG

Anti-Beta Interferon (PF-06823859)

IV infusion

Trial Locations (25)

4032

Debreceni Egyetem Klinikai Kozpont, Debrecen

10016

NYU Grossman School of Medicine, The Ronald O. Perelman Department of Dermatology, New York

NYU Langone Health Clinical Research Center, New York

10017

NYU Langone Radiology - Ambulatory Care Center East 41st Street, New York

10028

Mount Sinai Doctors Dermatology, New York

10029

Icahn School of Medicine at Mount Sinai, New York

19104

Center for Human Phenomic Science, Philadelphia

University of Pennsylvania, Perelman Center for Advanced Medicine (PCAM), Philadelphia

28041

Hospital Universitario 12 de Octubre, Madrid

32224

Mayo Clinic in Florida, Jacksonville

35233

University of Alabama at Birmingham, Birmingham

35294

University of Alabama at Birmingham, Department of Dermatology, Birmingham

44195

Cleveland Clinic Foundation, Cleveland

63108

Center for Outpatient Health, St Louis

Washington University School of Medicine, St Louis

63110

Washington University School of Medicine, St Louis

66160

KU Clinical and Translational Science Unit (CTSU) Rainbow, Kansas City

University of Kansas Medical Center, Kansas City

66205

KU Clinical Research Center - Clinical and Translational Science Unit (CTSU), Fairway

85259

Mayo Clinic, Scottsdale

90211

Attune Health Research Inc., Beverly Hills

02115

Brigham & Women's Hospital, Boston

Brigham and Women's Hospital - CTH, Boston

15-707

Nova Reuma Społka Partnerska, Bialystok

30-363

Centrum Medyczne Plejady, Krakow

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT05192200 - An Extension Study for Participants Who Have Completed the Treatment Period of a Qualifying Parent Study | Biotech Hunter | Biotech Hunter